bpc-157 legality just got voted in favor to be added to the 503A Bulk Drug Substances list, meaning a huge step towards being able to be prescribed and compounded in the US. Thank Rules and Risks of BPC-157

People with a history of cancer should be particularly wary, as IGF-1 (which increases with CJC-1295) may be involved in the development of certain types of cancer

What Tirzepatide Treats: Obesity, Type 2 Diabetes & Beyond Tirzepatide is a dual GIP/GLP-1 receptor agonist, which means it works on two distinct metabolic pathways simultaneously, making it one of the most powerful tools available in modern weight management

CL Answer Adrenal Fatigue and Adrenal Support Supplements: Do they work and are they safe

While PRP for Peyronies disease is still considered investigational , results to date are promising, and ongoing research continues to refine protocols and patient selection